Remote Vitals Care
Removi develops a wrist-worn ECG device enabling continuous cardiac monitoring and early detection of atrial fibrillation — wherever the patient is.
In nearly 1 in 5 stroke patients, atrial fibrillation is only discovered during the hospitalisation that follows.
Vision
Right now, we’re focused on detecting atrial fibrillation — one of the most common cardiac arrhythmias, and one that often goes unnoticed until real damage is done. It’s where we start, not where we stop: our long-term aim is remote monitoring and diagnostics for the critical conditions that shape people’s lives, wherever they are.
The product
Removi’s device captures ECG data continuously and streams it securely to clinical staff — enabling remote monitoring and automated arrhythmia detection.
Design concept
01
Continuous ECG capture without interruption to daily life. The device records every heartbeat — at rest, during activity, and through the night.
02
Clinicians view real-time data and receive automated alerts through a secure dashboard. No appointment needed.
03
Onboard algorithms continuously analyse rhythm patterns and flag arrhythmia episodes for immediate clinical review.
Applications
At its core, Removi is a remote monitoring device: two wristbands that follow the patient continuously, wherever they are. The same device serves different clinical needs.
A continuous single-lead ECG, recorded over extended periods while the patient goes about daily life. The aim is to detect atrial fibrillation and other arrhythmias, including episodes that come and go, and give clinicians the recording they need to make a diagnosis.
For patients hospitalised at home, Removi follows vital signs such as heart rate and rhythm continuously, so the clinical team can keep track of the patient's overall condition. The focus is not on a specific arrhythmia; the aim is to detect signs of deterioration early.
Removi is in development. Intended uses are subject to clinical validation and regulatory approval.
Technology
From the patient’s wrist to the clinician’s screen — three steps that turn continuous heart signals into actionable insight.
A medical-grade ECG sensor on the wrist records the heart’s electrical signal continuously, sampling every heartbeat day and night without disrupting daily life.
On-device algorithms process the raw signal in real time, filtering noise and screening rhythm patterns for the irregularities that characterise atrial fibrillation.
Findings stream securely and encrypted to a clinical dashboard, where staff review the data remotely and receive automated alerts the moment an episode is detected.
Medical-grade signal
Single-lead ECG quality validated against clinical reference standards.
Edge processing
Arrhythmia screening runs on the device to minimise latency and data load.
Secure by design
End-to-end encryption and privacy built to meet healthcare data requirements.
Clinical integration
Data delivered in a format that fits existing hospital and remote-care workflows.
The team
We are a cross-disciplinary team from the Technical University of Denmark, combining expertise in medical technology, software engineering, and healthcare systems.
News & updates
Follow our progress as we build toward continuous, clinically actionable cardiac monitoring.
We have moved into DTU Skylab, DTU’s innovation hub, to accelerate development of our wrist-worn ECG device.
Our early hardware prototype is entering internal bench testing — more details to follow as we validate the signal quality.
We are in conversation with clinicians and institutions interested in piloting continuous remote cardiac monitoring.
Partners & contact
If you are a clinician, hospital, investor, or research institution interested in remote cardiac monitoring — we would like to hear from you.
Partners
DTU Skylab
DTU’s Innovation Hub
TUH
Technical University Hospital
Regulatory
Removi is developing a medical device, and we are early in that journey. We are actively working toward the regulatory approvals required to bring continuous cardiac monitoring safely to patients and clinicians.
Our device is currently in development and is not yet certified or approved for clinical use. We are committed to meeting the applicable medical device regulations and clinical standards as we progress, and we will not make claims about clinical performance until they have been properly validated.
